The 2-Minute Rule for AV-101
are high when compared with present cefepime breakpoints, better breakpoints of cefepime/zidebactam can be warranted for AcinetobacterThe true consequences of the new cefepime mixtures will probably only be founded when examined versus severe MDR infections in well-executed pragmatic randomized trials.This was a big offer for folk who had been seei